Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland.
WorldWide Antimalarial Resistance Network, Oxford, UK.
Malar J. 2018 Feb 8;17(1):75. doi: 10.1186/s12936-018-2185-9.
To limit the spread and impact of anti-malarial drug resistance and react accordingly, surveillance systems able to detect and track in real-time its emergence and spread need to be strengthened or in some places established. Currently, surveillance of anti-malarial drug resistance is done by any of three approaches: (1) in vivo studies to assess the efficacy of drugs in patients; (2) in vitro/ex vivo studies to evaluate parasite susceptibility to the drugs; and/or (3) molecular assays to detect validated gene mutations and/or gene copy number changes that are associated with drug resistance. These methods are complementary, as they evaluate different aspects of resistance; however, standardization of methods, especially for in vitro/ex vivo and molecular techniques, is lacking. The World Health Organization has developed a standard protocol for evaluating the efficacy of anti-malarial drugs, which is used by National Malaria Control Programmes to conduct their therapeutic efficacy studies. Regional networks, such as the East African Network for Monitoring Antimalarial Treatment and the Amazon Network for the Surveillance of Antimalarial Drug Resistance, have been set up to strengthen regional capacities for monitoring anti-malarial drug resistance. The Worldwide Antimalarial Resistance Network has been established to collate and provide global spatial and temporal trends information on the efficacy of anti-malarial drugs and resistance. While exchange of information across endemic countries is essential for monitoring anti-malarial resistance, sustainable funding for the surveillance and networking activities remains challenging. The technology landscape for molecular assays is progressing quite rapidly, and easy-to-use and affordable new techniques are becoming available. They also offer the advantage of high throughput analysis from a simple blood spots obtained from a finger prick. New technologies combined with the strengthening of national reference laboratories in malaria-endemic countries through standardized protocols and training plus the availability of a proficiency testing programme, would contribute to the improvement and sustainability of anti-malarial resistance surveillance networks worldwide.
为了限制抗疟药物耐药性的传播和影响,并做出相应反应,需要加强或在某些地方建立能够实时检测和跟踪其出现和传播的监测系统。目前,抗疟药物耐药性监测采用以下三种方法之一:(1)体内研究评估药物在患者中的疗效;(2)体外/离体研究评估寄生虫对药物的敏感性;和/或(3)分子检测以检测与耐药性相关的已验证基因突变和/或基因拷贝数变化。这些方法是互补的,因为它们评估了耐药性的不同方面;然而,方法的标准化,特别是体外/离体和分子技术,仍然缺乏。世界卫生组织制定了评估抗疟药物疗效的标准方案,国家疟疾控制规划用于开展其治疗效果研究。已经建立了东非监测抗疟治疗网络和亚马逊监测抗疟药物耐药性网络等区域网络,以加强区域监测抗疟药物耐药性的能力。建立了全球抗疟药物耐药性网络,以整理和提供关于抗疟药物疗效和耐药性的全球时空趋势信息。虽然在监测抗疟耐药性方面,国家之间的信息交流至关重要,但监测和网络活动的可持续资金仍然具有挑战性。分子检测技术领域发展非常迅速,易于使用且价格合理的新技术正在出现。它们还具有从手指刺取的简单血斑进行高通量分析的优势。新技术与通过标准化协议和培训加强疟疾流行国家的国家参考实验室以及提供能力验证计划相结合,将有助于改善和维持全球抗疟耐药性监测网络。